Neurovascular disease is a condition caused to nervous tissues vascular structure, neurons and blood vessels that leads to serious brain damages such as stroke, and cerebral hemorrhage. The global market for central nervous system disease was accounted to approximately $78 billion in 2010.
Neurovascular Market is set to grow at a remarkable pace in the coming years. Neurovascular disease market is mainly driven by the increase in number of patients suffering from neurological diseases. According to University of California, San Francisco (USCF), there are approximately 600,000 people suffering from stroke, out of which 10% are recovered. Almost 30% patients die due to stroke, and 60% of the patients remain disabled. The cost of care for these 60% patients accounted to approximately $8 billion. Cost of neurological disease treatment is lowering the growth for neurological disease. Companies are conducting clinical trials to commercialized cost effective therapies through mergers and acquisitions.
Medical device manufacturing companies are facing challenges in the form of commercialization in developing countries such as India, China, and Malaysia. However, increase in research on neurovascular therapies, and favorable government policies, would give the necessary push to the neurovascular market. This report gives intelligence about current market trends available and transition of these trends in future. Market intelligence of key patents granted by respective authorities is provided in this report.
Get the PDF brochure of this market insight @
https://www.alliedmarketresearch.com/request-toc-and-sample/100
The key companies included in this report are Medtronic, Stryker, Covidien (Ev3) , Johnson & Johnson (Micrus), Abbott Laboratories, Bayer AG, Boston Scientific Corporation, Cardiatis, S.A., Chestnut Medical Technologies, Inc., Johnson & Johnson, ITGI Medical Ltd.
KEY MARKET SEGMENTS
GLOBAL MARKET, BY THERAPEUTICS
- Endovascular cerebral aneurysm
- Intracranial atherosclerotic disease
- Chronic ischemic stroke
- Acute ischemic stroke
GLOBAL MARKET, BY DEVICES
- Neurovascular liquid embolism
- Intracranial stents & flow diverting devices
- Neurovascular embolic coils
- Carotid stents & embolic protection devices
- Neurovascular thrombectomy devices
GLOBAL MARKET, BY GEOGRAPHY
- North America
- Europe
- Asia-Pacific
- ROW
KEY AUDIENCES
- Medical device manufacturing companies
- Research based pharmaceutical companies
- Academic Institutes
- Government and Private research laboratories